Pfizer Inc and Pharmacia Corporation jointly announced today that they have signed a definitive agreement providing for Pfizer to acquire Pharmacia in a stock-for-stock transaction valued at $60 billion, expanding the company's core strengths in pharmaceuticals and health care. Pharmacia also announced that its Board of Directors intends to proceed with its previously announced spin-off of its remaining 84% ownership of Monsanto to its current shareholders. "This is an extraordinary ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock the Printer-friendly, you'll also gain access to exclusive premium content.

Already registered? here.